Yes. And no.
Let us explain. There’s absolutely no doubt that we’re on the verge of change here (and we’ll look at this more closely a little later). But calling CBD oil the UK’s new ‘super drug’ seems a little cheap, right? It makes CBD oil seem like a hot trend. But it’s not.
What is a ‘Super Drug’?
Usually when we talk about ‘super drugs’, we’re talking about something new. Something powerful. Something dangerous. A flash-in-the-pan that ‘goes viral’; a rapidly emerging new medicine that’s on the tip of everyone’s lips for five minutes before people get bored and move onto whatever’s next. It’s exactly the same with superfoods. We mean, it wasn’t long ago that we were swimming in a sea of goji berries. Now we’ve moved onto kombucha. The ‘super’ industry is pretty fickle.
This isn’t at all what’s happening with CBD oil. First off, CBD isn’t a new discovery like other ‘super drugs’. And we’re sure the Flower Power era would have something to say about us 21st century folk claiming it was. Second of all, while CBD may be powerful, it’s not powerful in the way you’d usually associate with a ‘super drug’; it doesn’t create massive, obvious changes in the body. And third of all, CBD isn’t dangerous. Even the World Health Organization says it’s ‘generally well tolerated with a good safety profile’.
So we can pretty much rule out CBD oil being your typical ‘super drug’. But that’s not to say we’re not at a really exciting turning point in the emergence of CBD oil as a hugely beneficial supplement in the UK. Overall, we think that ‘super drug’ is a poor term for what CBD oil really is. What we have here is a supplement with epic potential.
A Supplement With Epic Potential
If we look again at the WHO document above, we can see that the organisation has noted that CBD oil has neuroprotective, antiepileptic, hypoxia-ischemia, anxiolytic, antipsychotic, analgesic, anti-inflammatory, anti-asthmatic, and antitumor properties.
The document lists 18 – yep, 18 – conditions that these properties could help to manage:
- Alzheimer’s Disease
- Parkinson’s Disease
- Multiple Sclerosis
- Huntington’s Disease
- Hypoxia-Ischemia Injury
- Inflammatory diseases
- Rheumatoid Arthritis
- Crohn’s Disease
- Cardiovascular Disease
- Diabetic complications
This is incredible. The fact that respected organisations like WHO are coming forward and acknowledging the potential of CBD as a beneficial supplement is amazing.
And they’re not the only ones…
The British heart foundation: Inflammation is part of the process that leads to many diseases, including coronary heart disease, high blood pressure and stroke, and there is some evidence that CBD has anti-inflammatory properties.
Epilepsy Action: Studies suggest that CBD may be an effective treatment for children with some types of hard-to-treat epilepsy.
Prostate Cancer UK: Cannabinoids may stop prostate cancer cells from growing and dividing, cause prostate cancer cells to die, and stop prostate cancer cells from invading other tissues and spreading.
The Brain Tumour Charity: There’s now conclusive evidence for the use of cannabis and its products, such as cannabis oil and CBD oil, for other therapeutic purposes, i.e. pain relief and treating chemotherapy-induced nausea and vomiting.
MS Society: Our medical advisors believe that about one in ten people with MS with pain or muscle spasticity might benefit from cannabis treatment
All this is making CBD oil a norm, rather than an anomaly. It’s no longer something that people look at and sort of shy away from not knowing whether or not it’s OK to consider; it’s something that is gradually and organically (again, a complete contrast to the media pushes of ‘super drugs’) becoming a natural and accepted part of life.
This is easy to see when we look at public perception. Reports show that around half of Brits now support the legalisation of cannabis (the plant that CBD oil is derived from), and about one third admit to having tried CBD oil (with 61% saying it works for them). Oils are the most commonly tried CBD product accounting for 26% of usage in the UK, followed by 21% using vaping oils, 16% taking capsules, 15% eating gummies, 13% consuming CBD drinks, and 9% using cosmetics and other topical beauty products.
An Exciting Time
CBD oil is basically hitting all the positive criteria for being listed as a ‘super drug’, without any of the negative associations or connotations. And that’s exciting. It means we’ve got this substance that’s got no reason not to be taken seriously; it’s got no reason to simply be lumped together with all the other ‘super drugs’ that have come and gone over the years. We’ve got a possible ‘super drug’ here that may thrive.
And to be honest, it’s looking likely. The current CBD market in the UK is valued at £300 million, but experts are predicting this will grow to £1 billion by 2025 as the number of users continues to rise. In just 12 months between 2017 and 2018, the number of Brits using CBD oil rose from 125,000 to 250,000, and that figure is going to keep growing.